New Delhi: Corona vaccination has been going on at a rapid pace in the country for some time now, while Johnson & Johnson Company has claimed that its same dose vaccine is effective in fighting against delta variants. Although the results of the new study are early, they are promising. The researchers analyzed the blood of 10 people who were vaccinated with the same-dose Johnson & Johnson vaccine. It was also examined against several other variants including Delta.
In the same investigation, they found that the vaccine was seen working against the new variant. The Vice-Chairman and Chief Scientific Officer of the Executive Committee of Johnson & Johnson, Dr. Paul Staffels said the new study has strengthened the ability of the Johnson & Johnson Corona vaccine to help protect the health of people globally. Earlier data has indicated that other vaccines made by Pfizer and Moderna are also likely to fight against delta variants.
But some experts have expressed concern over Johnson & Johnson's vaccine, which includes only one dose compared to others. Dr. Beth, Director, Centre for Virology and Vaccine Research at Israel Decones Medical Center. ''I would say it is reassuring," said Dan Baroch, who helped to lead the research. We also pointed out that we found that Johnson & Johnson's vaccine motivates antibodies to be deactivated. Baroch said another reassuring result of the study was that people vaccinated with Johnson & Johnson shots saw a strong immune system response until eight months later.
New IT Rules: Google and Koo submit their report to govt, but Twitter not agreeing
Karnataka: Negative RT-PCR report compulsorily for those coming from Kerala
Madhuri Dixit to make her first digital debut, will be seen in this famous producer's web series